Montefiore Health Systems (Montefiore Medical Center) (Data Collection Only)
Welcome,         Profile    Billing    Logout  
 19 Trials 
19 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mesias, Jesus D Anampa
NCT03941730: Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer

Enrolling by invitation
2
38
US
Biopsy, BIOPSY_TYPE, Bx, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized Tomography, CT, CT Scan, tomography, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT, Therapeutic Estradiol, 17 Beta-Estradiol, Aquadiol, Climara, Dimenformon, Diogyn, Diogynets, Estrace, ESTRADIOL, Estraldine, Oestradiol, Ovocylin, Progynon, Vagifem
Mayo Clinic, National Cancer Institute (NCI)
Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Recurrent Breast Carcinoma
07/26
07/26
NCT05554354: Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)

Recruiting
2
95
US
Binimetinib, ARRY-162, ARRY-438162, MEK162, Mektovi, Biopsy, BIOPSY_TYPE, Bx, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Scan, Bone Scintigraphy, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Fulvestrant, Faslodex, Faslodex(ICI 182,780), ICI 182,780, ICI 182780, ZD9238, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning
National Cancer Institute (NCI), NRG Oncology
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast Carcinoma
11/26
11/26
NCT03988595: Exercise Treatment With Standard Therapy for Metastatic Breast Cancer

Recruiting
1
53
US
Exercise Treatment
Memorial Sloan Kettering Cancer Center
Hormone Receptor Positive Metastatic Breast Cancer
08/24
08/24
NCT04962529: Breast Cancer Liquid Biopsy Trial

Recruiting
N/A
450
Canada, US
Blood Draw
Anthony Magliocco, Epic Sciences, DHR Health Institute for Research and Development, Memorial Healthcare System, University of Saskatchewan, Florida Cancer Specialist, Montefiore Medical Center, Ocala Oncology, NY Health d/b/a New York Cancer and Blood Specialists, Northwest Community Healthcare
Breast Cancer, Cancer
06/23
07/23
Sparano, Joseph
TAILORx, NCT00310180: Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The Trial)

Active, not recruiting
3
10273
Europe, Canada, US, RoW
Anastrozole, Anastrazole, Arimidex, ICI D1033, ICI-D1033, ZD-1033, Exemestane, Aromasin, FCE-24304, Laboratory Biomarker Analysis, Letrozole, CGS 20267, Femara, Fempro, Quality-of-Life Assessment, Quality of Life Assessment, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Tamoxifen Citrate, Apo-Tamox, Clonoxifen, Dignotamoxi, Ebefen, Emblon, Estroxyn, Fentamox, Gen-Tamoxifen, Genox, ICI 46,474, ICI-46474, Jenoxifen, Kessar, Ledertam, Lesporene, Nolgen, Noltam, Nolvadex, Nolvadex-D, Nourytam, Novo-Tamoxifen, Novofen, Noxitem, Oestrifen, Oncotam, PMS-Tamoxifen, Soltamox, TAM, Tamax, Tamaxin, Tamifen, Tamizam, Tamofen, Tamoxasta, Tamoxifeni Citras, Zemide
National Cancer Institute (NCI), American College of Surgeons, Cancer and Leukemia Group B, NSABP Foundation Inc, NCIC Clinical Trials Group, North Central Cancer Treatment Group, SWOG Cancer Research Network
Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Stage IIIB Breast Cancer AJCC v7
03/18
09/30
NCT02206984: Endocrine Response in Women With Invasive Lobular Breast Cancer

Active, not recruiting
2
201
US
Tamoxifen, Anastrozole, Fulvestrant
Priscilla McAuliffe
Breast Cancer
07/24
07/24
NCT03709446: Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Recruiting
1/2
54
US
Leflunomide, Arava
Joseph Sparano
Breast Neoplasms, Breast Diseases, Metastatic Triple Negative Breast Cancer
10/25
10/26
NCT01351909: Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Checkmark P2 interim data - SABCS
Dec 2011 - Dec 2011: P2 interim data - SABCS
Active, not recruiting
1
35
US
Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B-518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, WR-138719, Laboratory Biomarker Analysis, Veliparib, ABT-888, PARP-1 inhibitor ABT-888
National Cancer Institute (NCI)
Locally Advanced Unresectable Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
11/16
03/25
NCT03697577: Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Patients With ER+/HER2- Metastatic Breast Cancer

Recruiting
N/A
20
US
CT scans, DEXA scan
Montefiore Medical Center
Breast Cancer
12/25
12/25
TMEM-MRI, NCT03694756: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

Recruiting
N/A
75
US
TMEM-MRI, FNA
Montefiore Medical Center
Breast Cancer
12/24
12/24
NHLBI-MDS, NCT02775383: The National Myelodysplastic Syndromes (MDS) Study

Recruiting
N/A
3500
US, RoW
Therapeutic
National Heart, Lung, and Blood Institute (NHLBI), National Cancer Institute (NCI)
Myelodysplastic Syndromes (MDS)
03/25
03/25
Iyengar, Neil
NCT04298086: A Study of the Body's Response to Exercise and a Plant-Based Diet in Overweight Postmenopausal Women With Breast Cancer

Active, not recruiting
2
43
US
Exercise Treatment, Plant-Based Diet, Physical activity, Nutrition counseling, Replication Exercise Test
Memorial Sloan Kettering Cancer Center, American Cancer Society, Inc., McGill University, University of Kansas Medical Center, Wake Forest University
Breast Cancer, Primary Hormone Receptor Positive Breast Cancer
03/25
03/25
CA209-8H3, NCT03650894: Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

Active, not recruiting
2
30
US
Nivolumab, Opdivo, Ipilimumab, Yervoy, Bicalutamide, Casodex
Providence Health & Services, Bristol-Myers Squibb, Memorial Sloan Kettering Cancer Center
Breast Neoplasm Female, Breast Cancer, Breast Carcinoma, Breast Tumor
08/24
04/26
TIFA, NCT05090358: Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer

Active, not recruiting
2
15
US
Ketogenic Diet, Low Carbohydrate Diet, Alpelisib, Piqray, Fulvestrant, Faslodex, Canagliflozin, Invokana
Memorial Sloan Kettering Cancer Center
Breast Cancer, Breast Cancer Stage IV, Metastatic Breast Cancer
10/24
10/24
ARETHA, NCT05570253: A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Recruiting
2
55
US
Eribulin, SDX-7320, Placebo
Memorial Sloan Kettering Cancer Center, SynDevRx, Inc.
Breast Cancer, Metastatic Triple-Negative Breast Cancer
10/27
10/27
NCT03988595: Exercise Treatment With Standard Therapy for Metastatic Breast Cancer

Recruiting
1
53
US
Exercise Treatment
Memorial Sloan Kettering Cancer Center
Hormone Receptor Positive Metastatic Breast Cancer
08/24
08/24
NCT02713022: Body Composition and White Adipose Tissue Inflammation

Completed
N/A
202
US
DEXA Scan, Godin Leisure Time Exercise Questionnaire (GLTEQ)
Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University
Breast Cancer, Prostate Cancer, Body Composition, White Adipose Tissue Inflammation
11/23
11/23
NCT02494869: Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast Cancer

Active, not recruiting
N/A
75
US
Nonlinear Aerobic Training, Height, Weight, BMI measure, Blood draw, Cardiopulmonary exercise test
Memorial Sloan Kettering Cancer Center
High Risk for Developing Breast Cancer
07/24
07/24
NCT04589468: Researching the Effect of Exercise on Cancer

Recruiting
N/A
70
US
Exercise
Memorial Sloan Kettering Cancer Center
Breast Cancer, Prostate Cancer, Colorectal Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer, Stage I Colorectal Cancer, Stage II Colorectal Cancer, Stage III Colorectal Cancer
10/24
10/24

Download Options